Trials / Terminated
TerminatedNCT01381731
A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this trial are to: * Assess the safety and tolerability of diquafosol tetrasodium ophthalmic solution versus placebo following one week of treatment in subjects undergoing photorefractive keratectomy (PRK). * Evaluate the potential of diquafosol to accelerate corneal wound healing/re-epithelialization following PRK.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | diquafosol tetrasodium ophthalmic solution 2% | opthalmic solution 2 drops in each eye QID |
| DRUG | placebo | opthalmic solution 2 drops in each eye QID |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2011-06-27
- Last updated
- 2015-11-25
Source: ClinicalTrials.gov record NCT01381731. Inclusion in this directory is not an endorsement.